The preparation and storage of dried-blood spot quality control materials for lysosomal storage disease screening tests

Clinical Biochemistry

Volumn 44, Issue 8-9, 2011, Pages 704-710

  Adam, B W ^a   Orsini, J J ^b   Martin, M ^b   Hall, E M ^c   Zobel, S D ^a   Caggana, M ^b   Hannon, W H ^d  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b WADSWORTH CENTER   (United States)

^c BATTELLE MEMORIAL INSTITUTE   (United States)

^d NONE   (United States)

Author keywords

Dried blood spot; Lysosomal storage diseases; Newborn screening; Quality control; Storage stability; Tandem mass spectrometry; Umbilical cord blood

Indexed keywords

FRESH FROZEN PLASMA; LYSOSOME ENZYME;

ARTICLE; CONTROLLED STUDY; DRIED BLOOD SPOT; ENZYME ACTIVITY; FEMALE; HUMAN; HUMIDITY; LEUKOCYTE; LYSOSOME STORAGE DISEASE; MAJOR CLINICAL STUDY; MALE; NEWBORN; PRIORITY JOURNAL; QUALITY CONTROL; SCREENING TEST; UMBILICAL CORD BLOOD;

ADULT; CLINICAL ENZYME TESTS; FEMALE; HUMANS; INFANT, NEWBORN; LYSOSOMAL STORAGE DISEASES; LYSOSOMES; NEONATAL SCREENING; PREGNANCY; QUALITY CONTROL;

EID: 79955814605     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2011.02.014     Document Type: Article

References (24)

1. Parkinson-Lawrence E., Fuller M., Hopwood J.J., Meikle P.J., Brooks D.A. Immunochemistry of lysosomal storage disorders. Clin. Chem. 2006, 52:1660-1668.
2. Meikle P.J., Hopwood J.J., Clague A.E., Carey W.F. Prevalence of lysosomal disorders. JAMA 1999, 281:249-254.
3. Chamoles N.A., Blanco M., Gaggioli D. Fabry disease: enzymatic diagnosis in dried blood spots on filter paper. Clin. Chim. Acta 2001, 308:195-196.
4. Chamoles N.A., Blanco M., Gaggioli D., Casentini C. Gaucher and Niemann-Pick diseases-enzymatic diagnosis in dried blood spots on filter paper: retrospective diagnosis in newborn screening cards. Clin. Chim. Acta 2002, 317:191-197.
5. Li Y., Scott R., Chamoles N.A., et al. Direct multiplex assay of lysosomal enzymes in dried blood spots for newborn screening. Clin. Chem. 2004, 50:1785-1796.
6. Meikle P.J., Grasby D.J., Dean C.J., et al. Newborn screening for lysosomal storage disorders. Mol. Genet. Metab. 2006, 88:307-314.
7. Zhang X.K., Elbin C.S., Chuang W.L., et al. Multiplex enzyme assay screening of dried blood spots for lysosomal storage disorders by using tandem mass spectrometry. Clin. Chem. 2008, 54:1725-1728.
8. De Jesus V.R., Zhang X.K., Keutzer J., et al. Development and evaluation of quality control dried blood spot materials in newborn screening for lysosomal storage disorders. Clin. Chem. 2009, 55:158-164.
9. Orsini J.J., Morrissey M.A., Slavin L.N., et al. Implementation of newborn screening for Krabbe disease: population study and cutoff determination. Clin. Biochem. 2009, 42:877-884.
10. Millington D.S., Ramakrishna S., Eckhardt A. Digital microfluidics: a future technology in the newborn screening laboratory?. Semin. Perinatol. 2010, 34:163-169.
11. C.J. Bell (Ed), Newborn screening quality assurance program: 2010 annual summary report, 28 (2011) CDC, Atlanta. (Accessed March 2011). http://www.cdc.gov/labstandards/nsqap_reports.html.
12. B.W. Adam, J.J. Orsini, S.D. Stevens, and W.H. Hannon, Production of quality control materials for Krabbe disorder screening tests, Proceedings of the 2007 Newborn Screening and Genetic Testing Symposium, 2007 May 7-10, Minneapolis (MN). Silver Spring (MD): The Association of Public Health Laboratories; Omnipress; 2007.
13. J. Saavedra-Matiz, J. Orsini, M. Morrisey, et al, Newborn screening for Krabbe disease in New York state: the first months. Proceedings of the 2007 Newborn Screening and Genetic Testing Symposium; 2007 May 7-10; Minneapolis (MN). Silver Springs (MD): The Association of Public Health Laboratories; Omnipress; 2007.
14. Dajnoki A., Muhl A., Fekete G., et al. Newborn screening for Pompe disease by measuring acid α-glucosidase activity using tandem mass spectrometry. Clin. Chem. 2008, 54:1624-1629.
15. Dajnoki A., Fekete G., Keutzer J., et al. Newborn screening for Fabry disease by measuring GLA activity using tandem mass spectrometry. Clin. Chim. Acta 2010, 411:1428-1431.
16. Legini E., Orsini J.J., Hung C., et al. Analysis of glucocerebrosidase activity in dry blood spots using tandem mass spectrometry. Clin. Chim. Acta 2011, 412:343-346.
17. Delange F., Beckers C., Hofer R., et al. Neonatal screening for hypothyroidism in Europe: report of the Newborn Committee of the European Thyroid Association. Acta Endocrino Logica Supplementum 1979, 223:1-29. Copenhagen.
18. H. Zhou, V.R. De Jesus, R. Vogt, W.H. Hannon, Laboratory support at the Centers for Disease Control and Prevention for newborn bloodspot screening of lysosomal storage disorders, Proceedings of the 2010 Newborn Screening and Genetic Testing Symposium; 2010 May 3-6; Orlando (FL). Silver Spring (MD): The Association of Public Health Laboratories; Omnipress; 2010.
19. Chamoles N.A., Blanco M., Gaggioli D. Diagnosis of α-l-iduronase deficiency in blood spots on filter paper: the possibility of newborn diagnosis. Clin. Chem. 2001, 47:780-781.
20. Wang D., Eadala B., Sadilek M., et al. Tandem mass spectrometric analyses of dried blood spots for screening of mucopolysaccharidosis I in newborns. Clin. Chem. 2005, 51:898-900.
21. Blanchard S., Sadilek M., Scott C.R., et al. Tandem mass spectrometry for the direct assay of enzymes in dried blood spots: application to screening newborns for mucopolysaccharidosis. Clin. Chem. 2008, 54:2067-2070.
22. Duffey T.A., Bellamy G., Elliott S., et al. A tandem mass spectrometry triplex assay for the detection of Fabry, Pompe, and mucopolysaccharidosis-I (Hurler). Clin Chem 2010, 56:1854-1861.
23. Khaliq T., Sadilek M., Scott C.R., et al. Tandem mass spectrometry for the direct assay of lysosomal enzymes in dried blood spots: application to screening newborns for mucopolysaccharidosis IVA. Clin. Chem. 2011, 57:128-131.
24. Marsden D., Levy H. Newborn screening of lysosomal disorders. Clin. Chem. 2010, 56:1071-1079.